These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34007904)

  • 1. The changing face of Australian data reforms: impact on pharmacoepidemiology research.
    de Oliveira Costa J; Bruno C; Schaffer AL; Raichand S; Karanges EA; Pearson SA
    Int J Popul Data Sci; 2021 Apr; 6(1):1418. PubMed ID: 34007904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013).
    Pearson SA; Pesa N; Langton JM; Drew A; Faedo M; Robertson J
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):447-55. PubMed ID: 25833702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national study on prescribed medicine use in Australia on a typical day.
    Wylie CE; Daniels B; Brett J; Pearson SA; Buckley NA
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1046-1053. PubMed ID: 32779806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?
    Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dispensing patterns of emergency medicines prescribed by Australian dentists from 1992 to 2018 - a pharmacoepidemiology study.
    Park JS; Kruger E; Tennant M
    Int Dent J; 2020 Aug; 70(4):254-258. PubMed ID: 32170731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012.
    Harris C; Daniels B; Ward RL; Pearson SA
    Public Health Res Pract; 2017 Dec; 27(5):. PubMed ID: 31044212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future.
    Pearson SA; Pratt N; de Oliveira Costa J; Zoega H; Laba TL; Etherton-Beer C; Sanfilippo FM; Morgan A; Kalisch Ellett L; Bruno C; Kelty E; IJzerman M; Preen DB; Vajdic CM; Henry D
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of privacy-preserving record linkage to examine the dispensing of pharmaceutical benefits scheme medicines to pregnant women in Western Australia.
    Kelty E; Hansen M; Randall S; Gration D; Baynam G; Preen DB
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5845. PubMed ID: 38825961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data.
    Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL
    Med J Aust; 2023 Jul; 219(2):63-69. PubMed ID: 37230472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the dispensing patterns of antipsychotics in Australia from 2006 to 2018 - A pharmacoepidemiology study.
    Claassen JN; Park JS
    Res Social Adm Pharm; 2021 Jun; 17(6):1159-1165. PubMed ID: 32928657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers.
    Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA
    BMC Res Notes; 2015 Nov; 8():634. PubMed ID: 26526064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians.
    Pearson SA; Schaffer A
    BMJ Open; 2014 May; 4(5):e004099. PubMed ID: 24793244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
    Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
    Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme.
    Robertson J; Walkom EJ; Henry DA
    Aust Health Rev; 2009 May; 33(2):192-9. PubMed ID: 19563308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Australian Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: challenges and approaches.
    Page E; Kemp-Casey A; Korda R; Banks E
    Public Health Res Pract; 2015 Sep; 25(4):e2541546. PubMed ID: 26536508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine utilisation in Australia: report from a new pharmacoepidemiological database.
    Mant A; Whicker SD; McManus P; Birkett DJ; Edmonds D; Dumbrell D
    Aust J Public Health; 1993 Dec; 17(4):345-9. PubMed ID: 7911332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressivity of out-of-pocket costs under Australia's universal health care system: A national linked data study.
    Law HD; Marasinghe D; Butler D; Welsh J; Lancsar E; Banks E; Biddle N; Korda R
    Health Policy; 2023 Jan; 127():44-50. PubMed ID: 36456400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial costs associated with monopolies on biologic medicines in Australia.
    Gleeson D; Townsend B; Lopert R; Lexchin J; Moir H
    Aust Health Rev; 2019 Feb; 43(1):36-42. PubMed ID: 29116927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.